Advertisement
Singapore markets open in 48 minutes
  • Straits Times Index

    3,157.32
    -13.80 (-0.44%)
     
  • S&P 500

    5,078.18
    +8.65 (+0.17%)
     
  • Dow

    38,972.41
    -96.82 (-0.25%)
     
  • Nasdaq

    16,035.30
    +59.05 (+0.37%)
     
  • Bitcoin USD

    56,908.73
    +2,250.50 (+4.12%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,683.02
    -1.28 (-0.02%)
     
  • Gold

    2,037.90
    -6.20 (-0.30%)
     
  • Crude Oil

    78.38
    -0.49 (-0.62%)
     
  • 10-Yr Bond

    4.3150
    +0.0160 (+0.37%)
     
  • Nikkei

    39,239.52
    0.00 (0.00%)
     
  • Hang Seng

    16,790.80
    +156.06 (+0.94%)
     
  • FTSE Bursa Malaysia

    1,558.80
    +11.20 (+0.72%)
     
  • Jakarta Composite Index

    7,285.32
    -7,283.82 (-49.99%)
     
  • PSE Index

    6,860.67
    -30.82 (-0.45%)
     

FUJIFILM (FUJIY) & UCDI to Develop Hydrogen-Oxidizing Bacteria

FUJIFILM Holdings Corporation FUJIY has announced an agreement with the Utilization of Carbon Dioxide Institute or “UCDI” to develop technology for producing organic matter using hydrogen-oxidizing bacteria and carbon dioxide.

The companies are focusing on producing alanine, a type of amino acid, through mass fermentation of UCDI's unique hydrogen-oxidizing bacteria. The collaboration aims to achieve stable mass fermentation of UCDI Hydrogen Bacteria and develop mass production technology for alanine.

Hydrogen-oxidizing bacteria is a type of microorganism that can use carbon dioxide as a source of nutrition and rapidly produce organic matter through a carbon-negative process. This has garnered interest as a potential means of achieving a decarbonized society, which is a pressing issue for the global community.

Fujifilm Holdings Corp. Price and Consensus

Fujifilm Holdings Corp. Price and Consensus
Fujifilm Holdings Corp. Price and Consensus

Fujifilm Holdings Corp. price-consensus-chart | Fujifilm Holdings Corp. Quote

UCDI Hydrogen Bacteria possess advanced proliferative ability and can produce various organic matter, including amino acids and alcohol, through genetic modification.

Fujifilm has a history of using production technology, including microbial fermentation and cell culture, to manufacture biopharmaceuticals, and has also developed a next-generation continuous production system for integrated biopharmaceutical production.

In November, FUJIFILM announced an investment of $188 million to build a cell culture media manufacturing facility in North Carolina. The facility will help the company to tap into the growing demand for high-quality cell culture media solutions.

Prior to that, the company announced that it will establish a Japanese Bio-CDMO site in Toyama City to develop vaccines against future pandemics. It is expected to become operational by fiscal 2026. The company is investing ¥90 billion (roughly $850 Million) investment package to accelerate growth of its core Bio CDMO subsidiary.

FUJIFILM expects revenues of ¥2,800 billion for the current year, up from the earlier guidance of ¥2,700 billion, indicating growth of 10.9% year over year. The net income is expected to decline 5.3% year over year to ¥200 billion.

At present, FUJIY carries a Zacks Rank #3 (Hold). The stock has lost 14.2% in the past year compared with the sub-industry’s decline of 32.1%.

Zacks Investment Research
Zacks Investment Research


Image Source: Zacks Investment Research

Stocks to Consider

Some better-ranked stocks from the broader technology space are Arista Networks ANET, Jabil JBL and Super Micro Computer SMCI, each presently sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

The Zacks Consensus Estimate for Arista Networks 2022 earnings is pegged at $4.37 per share, up 8.2% in the past 60 days. The long-term earnings growth rate is anticipated to be 17.5%.

Arista Networks’ earnings beat the Zacks Consensus Estimate in the last four quarters, the average being 12.7%. Shares of ANET have declined 18.4% in the past year.

The Zacks Consensus Estimate for Jabil’s 2023 earnings is pegged at $8.31 per share, rising 1.6% in the past 60 days. The long-term earnings growth rate is anticipated to be 12%.

Jabil’s earnings beat the Zacks Consensus Estimate in all the last four quarters, the average being 8.9%. Shares of JBL have declined 3.6% in the past year.

The Zacks Consensus Estimate for Super Micro Computer’s fiscal 2023 earnings is pegged at $9.58 per share, rising 19.8% in the past 60 days.

Super Micro Computer’s earnings beat the Zacks Consensus Estimate in all the last four quarters, the average being 9.4%. Shares of SMCI have soared 83.6% in the past year.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Fujifilm Holdings Corp. (FUJIY) : Free Stock Analysis Report

Jabil, Inc. (JBL) : Free Stock Analysis Report

Super Micro Computer, Inc. (SMCI) : Free Stock Analysis Report

Arista Networks, Inc. (ANET) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research